Zymeworks (ZYME) Non-Current Deffered Revenue (2021 - 2026)

Zymeworks has reported Non-Current Deffered Revenue for 6 years, with the latest figure at $14.6 million in Q1 2026.

• Quarterly Non-Current Deffered Revenue changed 0.01% year-over-year to $14.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.6 million (changed 0.01% YoY) and the FY2025 annual result came in at $14.6 million, changed 0.01% from the prior year.
• Non-Current Deffered Revenue was little changed at $14.6 million in Q1 2026 per ZYME's latest filing, from $14.6 million in the prior quarter.
• Over five years, Non-Current Deffered Revenue peaked at $32.9 million in Q3 2022 and troughed at $14.6 million in Q4 2025.
• A 5-year average of $23.9 million and a median of $30.6 million in 2022 frame the typical range for Non-Current Deffered Revenue.
• The sharpest annual moves came in 2023 and 2024: Non-Current Deffered Revenue rose 7.69% in 2023, then sank 55.66% in 2024.
• Over 5 years, Non-Current Deffered Revenue stood at $30.6 million in 2022, then rose by 7.69% to $32.9 million in 2023, then tumbled by 55.66% to $14.6 million in 2024, then decreased by 0.01% to $14.6 million in 2025, then changed by 0.0% to $14.6 million in 2026.
• According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $14.6 million, $14.6 million, and $14.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.